Menopausal hormone therapy use and breast cancer risk in Australia: Findings from the New South Wales Cancer, Lifestyle and Evaluation of Risk study

Author:

Salagame Usha12,Banks Emily34,Sitas Freddy25,Canfell Karen126

Affiliation:

1. Cancer Research Division, Cancer Council NSW; Woolloomooloo NSW Australia

2. School of Public Health; Sydney Medical School, University of Sydney; Sydney NSW Australia

3. National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University; Canberra ACT Australia

4. Sax Institute; Sydney NSW Australia

5. School of Public Health and Community Medicine; University of New South Wales; Sydney NSW Australia

6. Prince of Wales Clinical School, University of New South Wales; Sydney NSW Australia

Funder

Tour De Cure

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. Ferlay J Soerjomataram I Ervik M http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx 2015

2. Breast cancer and hormone-replacement therapy in the Million Women Study;Beral;Lancet,2003

3. Medicines and Healthcare Products Regulatory Agency http://webarchive.nationalarchives.gov.uk/20080527191907/http 2015

4. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer;Collaborative Group on Hormonal Factors in Breast Cancer.;Lancet,1997

5. An epidemiological overview of the relationship between hormone replacement therapy and breast cancer;Salagame;Expert Rev Endocrinol Metab,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3